CES 2026 Spotlight: J-STYLE Showcases Smart Wearables and AI Remote Health Management Solutions GlobeNewswire January 08, 2026 Las Vegas, NV, Jan. 08, 2026 (GLOBE NEWSWIRE) — At CES 2026, Chinese innovator J-STYLE (Jointcorp / Youhong) drew global attention with its latest smart rings, AI smart bands, smart health watches, and biosensors integrated with a remote […]
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ:CORT) concerning potential violations of the federal securities laws. What Happened? • On December 31, 2025, Corcept announced it received a CRL from the FDA, denying
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc ("Mereo BioPharma Group plc") (NASDAQ:MREO) concerning potential violations of the federal securities laws. On December 29, 2025, before the market opened, Mereo announced results from its Phase 3
Infusion Pump Market is expected to generate a revenue of USD 24.09 Billion by 2031, Globally, at 6% CAGR: Verified Market Research(R) Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, “Infusion Pump Market Size and Forecast,”. Offering
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoRan Inc. (NYSE:FCX) securities. If you suffered a loss on your Freeport-McMoRan Inc. investment and would like to explore a potential
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. ("Ultragenyx Pharmaceutical Inc.") (NASDAQ:RARE) concerning potential violations of the federal securities laws. What Happened? • On December 29, 2025, Ultragenyx announced the results from both its Phase III Orbit
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Galectin Therapeutics Inc. ("Galectin Therapeutics Inc.") (NASDAQ:GALT) concerning potential violations of the federal securities laws. Galectin issued a press release on December 19, 2025, "announc[ing] that the U.S. Food and Drug Administration
WILMINGTON, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — KEV Group, the leading provider of K-12 school finance management solutions, today released The K-12 Fraud Report: Inside the School Finance Blind Spot Costing Districts Millions, uncovering a largely overlooked structural oversight gap in how school-level funds are managed and monitored across North America. Based on an
New K-12 Fraud Report Reveals $49 Million in Losses, Highlighting a Widespread School-Level Oversight Gap 97% of documented school fraud cases involve internal staff or volunteers, highlighting the urgent need for stronger visibility and financial controls inside schools GlobeNewswire January 08, 2026 WILMINGTON, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — KEV Group, the leading provider
Fluoropolymer Market is expected to generate a revenue of USD 772.96 Million by 2032, Globally, at 5.20% CAGR: Verified Market Research(R) Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, “Fluoropolymer Market Size and Forecast”. This meticulously crafted